Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung ... (ever we are already in a position to ini...)

Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections

Date:9/4/2008

ever, we are already in a position to initiate clinical trials to fully assess its safety and tolerability and gather information on appropriate doses. I am very pleased for patients suffering from cystic fibrosis, who will benefit directly from this promising once-a-day treatment: a significant improvement both in treatment and patient management. This is also great news for our investors, who have helped us to advance so far in a very short time."

Fluidosome(R) technology is based on the well characterised drug tobramycin. Utilising synthetic liposomes containing tobramycin, a standard nebulizer delivers the drug directly to the endobronchial sites of infection in cystic fibrosis patients. This results in prolonged, high local drug concentration, which in turn achieves higher efficacy and enables lower doses.

The phase II study will be carried out in 4 international centres. A total of 24 patients will receive treatment: Eight will receive a twice-daily 300 mg dose of the current tobramycin formulation over 28 days; another eight will be given a twice-daily 150 mg dose of Fluidosome(R) over two weeks and later a third group will receive one 300 mg dose of Fluidosome(R) per day for two weeks.

The company has also announced the appointment of two renowned experts to its Scientific Advisory Board. Prof. Adriano Aguzzi, Director of the Institute of Neuropathology at University Hospital Zurich, Switzerland and Prof. Gergely C. Lukacs, Canada Research Chair, Department of Physiology at McGill University Montreal, Canada will in future advise Axentis Pharma on scientific and medical issues related to the company's product pipeline.

Dr. Schreier on the latest additions to the team: "Axentis Pharma is very happy to have such outstanding experts on its Scientific Advisory Board. Just as our investors provide us with the trust and financial means that are essential to the ongoing development of our products, Prof. Aguzzi and Prof. Lukacs will cont
'/>"/>

SOURCE Axentis Pharma AG
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine technology :

1. Promising Cystic Fibrosis Compound on Track for Development
2. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
3. Pediatric Pulmonary Expert Comments on Study of Lung Transplants for Cystic Fibrosis
4. Cystic Fibrosis Foundation Reports Upward Trend for Key Health Outcomes
5. Cystic Fibrosis Foundation Announces Positive Early Results for Phase 2 Clinical Trial of VX-770 - an Oral Compound to Treat CF
6. Lung Transplants in Cystic Fibrosis Patients With Life-Threatening Bacteria Sparks Debate at ISHLT Meeting
7. PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis
8. PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity
9. Transave Announces Positive Phase II Results for Once-Daily Arikace(TM) in the Treatment of Cystic Fibrosis Patients Who Have Pseudomonas Lung Infections
10. Mpex Initiates a Phase 2 Clinical Trial of Aerosol MP-376 in the Treatment of Chronic Bacterial Infections in Cystic Fibrosis Patients
11. The Ocean Becomes a Pipeline To A Cure for Cystic Fibrosis

Post Your Comments:

(Date:5/20/2013)... WASHINGTON , May 20, 2013 Medicare ... networks are overwhelmingly satisfied, citing lower costs, convenient ... a new survey from Hart Research Associates released ... More than 40% of Part D seniors (9.5 ... networks. "Seniors like the lower costs, ...

(Date:5/19/2013)... 2013 Whole-cell pertussis vaccines were more effective at ... large recent outbreak, according to a new Kaiser Permanente ... also called DTwP, were available from the 1940s to ... led to the development of acellular pertussis vaccines, which ... the United States had switched from ...

(Date:5/17/2013)... -- The power of plants to cure and rejuvenate, ... depends on the plant kingdom, is the subject of ... Medicine: Healing Plants Around the World, Featuring ... 18 through September 8, 2013. (Photo: ... attractions include a re-creation of the Western world,s oldest ...

Breaking Medicine Technology:Survey: 85% of Part D Seniors in Preferred Pharmacy Plans are Satisfied With Costs, Pharmacy Choices 2 Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 2 Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 3 Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 4 Wild Medicine On View at The New York Botanical Garden Through Sept. 8 2

[0] Survey: 85% of Part D Seniors in Preferred Pharmacy Plans are Satisfied With Costs, Pharmacy Choices [0] Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak [0] Wild Medicine On View at The New York Botanical Garden Through Sept. 8

... (OTC Bulletin Board: AEMD ), the pioneer ... and cancer, announced today that it has engaged Fabiani ... partnerships that advance biodefense, cancer, and chronic infectious disease ... the first medical device to selectively target the removal ...

... LAIYANG, China, Sept. 30 /PRNewswire-Asia-FirstCall/ -- ... ... ... ,; var first_result; // Results are keyed by longUrl, so we need to grab the first ...

Aethlon Medical Engages Fabiani & Company to Advance U.S. Government Partnerships Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results

(Date:5/20/2013)... New York, New York (PRWEB) May 20, 2013 ... – Duncan Firm P.A. and Thrash Law Firm P.A., both ... to the final approval of the proposed $7.25 billion settlement ... over credit-card transaction fees. The objection was filed Wednesday, May ... District of New York. The related lawsuit against Visa and ...

(Date:5/20/2013)... This summer, digital health leaders from across ... pilgrimage to San Diego, CA, the emerging digital health ... Summit produced by Living in Digital Times. ... the latest digital health innovations, exchange new information, share ... of industry’s most brilliant thinkers and doers, while elevating ...

(Date:5/20/2013)... The nationwide law firm of Bernstein Liebhard LLP ... imaging (MRI) can be used to predict metal-on-metal hip ... experiencing symptoms. According to an article published on May ... MRI detected synovitis (tissue damage) in 68% of asymptomatic patients ... causes, the detection rate was 75%, while MRIs were able ...

(Date:5/20/2013)... (PRWEB) May 20, 2013 For more ... have waged a battle against drug and alcohol abuse ... has released its first guide to help Italian speakers ... published by the European Monitoring Centre for Drugs and ... four have used cannabis in the last year. As ...

(Date:5/20/2013)... many hospital intensive care units have a nighttime ... new research suggests this may have no clear ... hospitals in the United States and three-quarters of ... the ICU, the practice may unnecessarily increase health-care ... fewer resources, the study authors said. "Based ...

Breaking Medicine News(10 mins):Health News:Parker Waichman LLP Takes on the Credit Card Companies, Fights for Smaller Retailers that Form the U.S. Economy’s ‘Backbone’ 2 Health News:Parker Waichman LLP Takes on the Credit Card Companies, Fights for Smaller Retailers that Form the U.S. Economy’s ‘Backbone’ 3 Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 2 Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 3 Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 4 Health News:Metal-on-Metal Hip Replacement Lawyers Note New Study Finding MRIs Can Be Used to Predict Metal-on-Metal Hip Implant Failure 2 Health News:Metal-on-Metal Hip Replacement Lawyers Note New Study Finding MRIs Can Be Used to Predict Metal-on-Metal Hip Implant Failure 3 Health News:Metal-on-Metal Hip Replacement Lawyers Note New Study Finding MRIs Can Be Used to Predict Metal-on-Metal Hip Implant Failure 4 Health News:First Narconon Cannabis Abuse Prevention Guide Takes Aim at Drug Abuse Statistics for Italian Youth 2 Health News:Nighttime Docs at ICUs Don't Boost Patient Outcomes: Study 2

[0] Parker Waichman LLP Takes on the Credit Card Companies, Fights for Smaller Retailers that Form the U.S. Economy’s ‘Backbone’[0] Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego [0] Metal-on-Metal Hip Replacement Lawyers Note New Study Finding MRIs Can Be Used to Predict Metal-on-Metal Hip Implant Failure [0] First Narconon Cannabis Abuse Prevention Guide Takes Aim at Drug Abuse Statistics for Italian Youth [0] Nighttime Docs at ICUs Don't Boost Patient Outcomes: Study

... 11 private healthcare providers into the public NHS system thereby ... sector. //Mr Blair and the health secretary, Patricia Hewitt, welcomed ... to mark the launch of NHS Partners Network. ... towards 'future success' of the NHS. "Wherever people are treated ...

... are at a lesser risk of Parkinson’s, according to ... and Psychiatry. // ,The research team, as ... patients and 106 healthy people, belonging to the same ... sought to throw light on their personality traits and ...

... flu pandemic could claim as much as 140 million ... ,The authors of the report, internationally renowned ... academic Alexandra Sidorenko, estimate that even a mild pandemic ... economy $330 billion in lost production. ,The ...

... in Australia claims to have discovered a novel way ... attention deficit hyperactivity disorder (ADHD). //This novel method, space-age ... space. But it can also be used by the ... , ,Attention deficit hyperactivity disorder (ADHD) is a ...

... firm LG Electronics has said that it will start to ... filter made from using an enzyme contained in the "the ... against the dreaded bird flu virus. ,"We developed ... flu," LG spokeswoman Park Se-won said. The filter was fabricated ...

... are pushing Wal-Mart against a Wall, to cough up more on ... the unions are doing this for the cause of the workers, ... meets the eye. The scene is on the brink of a ... ,The scene at Washington is hotting up with the ...

Cached Medicine News:

Blair Welcomes 11 Private Healthcare Providers into NHS Adventure Enthusiasts, Risk Takers and Those Living on the Edge, Good News Coming Your Way Bird Flu Could Claim 140 Million Lives: Report Novel Treatment to Cure People with Learning Disabilities,LG To Market Air Conditioner Capable of Fighting Bird Flu Upgrade Health Benefits: Wal-Mart in a Tight Spot

Compact, bench-top analyser with minimal water volume requirements and easy waste management....

... source is a superior choice for machine ... headlamps, and dental curing. This is a ... weight, compact and cost competitve with lower ... source utilizes the latest in Cermax technology, ...

... Test System* is a multiplexed, fluorescent, ... multiple assays from a single sample ... a simple and streamlined alternative to ... clinical sensitivity and comparable clinical specificity ...

... 350 Chemistry System offers easy operation, maintenance, and ... STAT, or back-up to the powerful VITROS 5,1 ... the job done right the first time. Its ... are efficient, dependable, and easy-to-use. The VITROS 350 ...

Medicine Products:

Mira XL2000 Fiber Optic Light Source AtheNA Multi-Lyte Test System VITROS 350 Chemistry System